Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC43383 Secergan
Anticholinergic and ganglion-blocking agent
More description
DC43382 Shanzhiside
DC43381 Diapocynin
Inhibitor of ROS production, preventing PD symptoms in the LRRK2(R1441G) transgenic (tg) mouse model of PD
More description
DC43380 Silydianin
DC43379 Olivil
DC43378 Ganoderic acid Z
DC43377 Fulvestrant (ICI-182780)
Fulvestrant (ICI 182,780) is a selective estrogen receptor down-regulator (SERD). Fulvestrant is a high affinity estrogen receptor antagonist. Fulvestrant is the first "pure" antiestrogen with no agonistic activity both in vitro and in vivo.
More description
DC43376 Pseudolycorine
DC43375 MEL-3 Hydrochloride
Novel potent androgen receptor (AR) antagonist that suppresses prostate cancer cell growth
More description
DC43374 Lasiodin
DC43373 3,4-Dihydroxyphenylglycol
DC43372 Apigenin 5-O-beta-D-glucopyranoside
DC43371 Ezatiostat Hydrochloride
Novel inhibitor of glutathione S-transferase P1-1 (GSTP1-1)
More description
DC43370 Erythristemine
DC43369 Docosyl caffeate
DC43368 7-Geranyloxy-6-methoxycoumarin
DC43367 Petunidin-3-O-arabinoside chloride
DC43366 Petunidin-3-O-galactoside chloride
DC43365 Delphinidin-3-O-galactoside chloride
DC43364 Tomentin
DC43363 Bavachalcone
DC43362 Reynosin
DC43361 Dihydrodehydrodiconiferyl alcohol
DC43360 Peonidin-3-O-galactoside chloride
DC43359 Rediocide A
An Insecticide, induces G-protein-coupled receptor desensitization via activation of conventional protein kinase C
More description
DC43358 Ervamycine
DC43357 Erysotrine
DC43356 Communic acid
DC43355 Xanthohumol D
DC43354 Phyllostine

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X